Loading…
Regulation of phospholipase C isozymes by ras superfamily GTPases
The physiological effects of many extracellular stimuli are mediated by receptor-promoted activation of phospholipase C (PLC) and consequential activation of inositol lipid-signaling pathways. These signaling responses include the classically described conversion of PtdIns(4,5)P(2) to the Ca(2+)-mob...
Saved in:
Published in: | Annual review of pharmacology and toxicology 2006-01, Vol.46 (1), p.355-379 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c454t-fe63d3243b50318edd0689da38c6dd981a08d125995ecb5c8a7eb3c51821fa623 |
---|---|
cites | cdi_FETCH-LOGICAL-c454t-fe63d3243b50318edd0689da38c6dd981a08d125995ecb5c8a7eb3c51821fa623 |
container_end_page | 379 |
container_issue | 1 |
container_start_page | 355 |
container_title | Annual review of pharmacology and toxicology |
container_volume | 46 |
creator | HARDEN, T. Kendall SONDEK, John |
description | The physiological effects of many extracellular stimuli are mediated by receptor-promoted activation of phospholipase C (PLC) and consequential activation of inositol lipid-signaling pathways. These signaling responses include the classically described conversion of PtdIns(4,5)P(2) to the Ca(2+)-mobilizing second messenger Ins(1,4,5)P(3) and the protein kinase C-activating second messenger diacylglycerol as well as alterations in membrane association or activity of many proteins that harbor phosphoinositide binding domains. Here we discuss how the family of PLCs elaborates a minimal catalytic core typified by PLC-delta to confer multiple modes of regulation on their phospholipase activities. Although PLC-dependent signaling is prominently regulated by direct interactions with heterotrimeric G proteins or tyrosine kinases, the existence of at least 13 divergent PLC isozymes promises a diverse repertoire of regulatory mechanisms for this class of important signaling proteins. We focus here on the recently realized and extensive regulation of inositol lipid signaling by Ras superfamily GTPases directly acting on PLC isozymes and conclude by considering the biological and pharmacological ramifications of this regulation. |
doi_str_mv | 10.1146/annurev.pharmtox.46.120604.141223 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67618549</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1009295491</sourcerecordid><originalsourceid>FETCH-LOGICAL-c454t-fe63d3243b50318edd0689da38c6dd981a08d125995ecb5c8a7eb3c51821fa623</originalsourceid><addsrcrecordid>eNpdkF1LwzAUhoMoOqd_QYqg4EVrvtdcjqFTEBTR65Cmqetom5qzivPXG1lF8OJw4OXhPYcHoSuCM0K4vDZdNwT3kfUrE9qN_8y4zAjFEvOMcEIp20MTIrhIOcN8H00wkzQlktMjdAywxhgrxskhOooZpgqrCZo_u7ehMZvad4mvkn7lIU5T9wZcskhq8F_b1kFSbJNgIIGhd6Eybd1sk-XLU4TgBB1UpgF3Ou4per29eVncpQ-Py_vF_CG1XPBNWjnJSkY5KwRmJHdliWWuSsNyK8tS5cTgvCRUKCWcLYTNzcwVzAqSU1IZSdkUXe56--DfBwcb3dZgXdOYzvkBtJxJkguuInj-D1z7IXTxN02xiAinP23zHWSDBwiu0n2oWxO2mmD9I1uPsvWvbB2znWy9kx07zsZDQ9G68q9htBuBixEwYE1TBdPZGv64mWBC4Rn7BgnUjY8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>205854422</pqid></control><display><type>article</type><title>Regulation of phospholipase C isozymes by ras superfamily GTPases</title><source>Annual Reviews</source><creator>HARDEN, T. Kendall ; SONDEK, John</creator><creatorcontrib>HARDEN, T. Kendall ; SONDEK, John</creatorcontrib><description>The physiological effects of many extracellular stimuli are mediated by receptor-promoted activation of phospholipase C (PLC) and consequential activation of inositol lipid-signaling pathways. These signaling responses include the classically described conversion of PtdIns(4,5)P(2) to the Ca(2+)-mobilizing second messenger Ins(1,4,5)P(3) and the protein kinase C-activating second messenger diacylglycerol as well as alterations in membrane association or activity of many proteins that harbor phosphoinositide binding domains. Here we discuss how the family of PLCs elaborates a minimal catalytic core typified by PLC-delta to confer multiple modes of regulation on their phospholipase activities. Although PLC-dependent signaling is prominently regulated by direct interactions with heterotrimeric G proteins or tyrosine kinases, the existence of at least 13 divergent PLC isozymes promises a diverse repertoire of regulatory mechanisms for this class of important signaling proteins. We focus here on the recently realized and extensive regulation of inositol lipid signaling by Ras superfamily GTPases directly acting on PLC isozymes and conclude by considering the biological and pharmacological ramifications of this regulation.</description><identifier>ISSN: 0362-1642</identifier><identifier>EISSN: 1545-4304</identifier><identifier>DOI: 10.1146/annurev.pharmtox.46.120604.141223</identifier><identifier>PMID: 16402909</identifier><language>eng</language><publisher>Palo Alto, CA: Annual Reviews</publisher><subject>Analytical, structural and metabolic biochemistry ; Animals ; Biological and medical sciences ; Enzymes and enzyme inhibitors ; Fundamental and applied biological sciences. Psychology ; Gene Expression Regulation, Enzymologic - physiology ; Humans ; Isoenzymes - genetics ; Isoenzymes - physiology ; ras GTPase-Activating Proteins - genetics ; ras GTPase-Activating Proteins - physiology ; Transferases ; Type C Phospholipases - biosynthesis ; Type C Phospholipases - genetics ; Type C Phospholipases - physiology</subject><ispartof>Annual review of pharmacology and toxicology, 2006-01, Vol.46 (1), p.355-379</ispartof><rights>2006 INIST-CNRS</rights><rights>Copyright Annual Reviews, Inc. 2006</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c454t-fe63d3243b50318edd0689da38c6dd981a08d125995ecb5c8a7eb3c51821fa623</citedby><cites>FETCH-LOGICAL-c454t-fe63d3243b50318edd0689da38c6dd981a08d125995ecb5c8a7eb3c51821fa623</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4182,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17535907$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16402909$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>HARDEN, T. Kendall</creatorcontrib><creatorcontrib>SONDEK, John</creatorcontrib><title>Regulation of phospholipase C isozymes by ras superfamily GTPases</title><title>Annual review of pharmacology and toxicology</title><addtitle>Annu Rev Pharmacol Toxicol</addtitle><description>The physiological effects of many extracellular stimuli are mediated by receptor-promoted activation of phospholipase C (PLC) and consequential activation of inositol lipid-signaling pathways. These signaling responses include the classically described conversion of PtdIns(4,5)P(2) to the Ca(2+)-mobilizing second messenger Ins(1,4,5)P(3) and the protein kinase C-activating second messenger diacylglycerol as well as alterations in membrane association or activity of many proteins that harbor phosphoinositide binding domains. Here we discuss how the family of PLCs elaborates a minimal catalytic core typified by PLC-delta to confer multiple modes of regulation on their phospholipase activities. Although PLC-dependent signaling is prominently regulated by direct interactions with heterotrimeric G proteins or tyrosine kinases, the existence of at least 13 divergent PLC isozymes promises a diverse repertoire of regulatory mechanisms for this class of important signaling proteins. We focus here on the recently realized and extensive regulation of inositol lipid signaling by Ras superfamily GTPases directly acting on PLC isozymes and conclude by considering the biological and pharmacological ramifications of this regulation.</description><subject>Analytical, structural and metabolic biochemistry</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Enzymes and enzyme inhibitors</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gene Expression Regulation, Enzymologic - physiology</subject><subject>Humans</subject><subject>Isoenzymes - genetics</subject><subject>Isoenzymes - physiology</subject><subject>ras GTPase-Activating Proteins - genetics</subject><subject>ras GTPase-Activating Proteins - physiology</subject><subject>Transferases</subject><subject>Type C Phospholipases - biosynthesis</subject><subject>Type C Phospholipases - genetics</subject><subject>Type C Phospholipases - physiology</subject><issn>0362-1642</issn><issn>1545-4304</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNpdkF1LwzAUhoMoOqd_QYqg4EVrvtdcjqFTEBTR65Cmqetom5qzivPXG1lF8OJw4OXhPYcHoSuCM0K4vDZdNwT3kfUrE9qN_8y4zAjFEvOMcEIp20MTIrhIOcN8H00wkzQlktMjdAywxhgrxskhOooZpgqrCZo_u7ehMZvad4mvkn7lIU5T9wZcskhq8F_b1kFSbJNgIIGhd6Eybd1sk-XLU4TgBB1UpgF3Ou4per29eVncpQ-Py_vF_CG1XPBNWjnJSkY5KwRmJHdliWWuSsNyK8tS5cTgvCRUKCWcLYTNzcwVzAqSU1IZSdkUXe56--DfBwcb3dZgXdOYzvkBtJxJkguuInj-D1z7IXTxN02xiAinP23zHWSDBwiu0n2oWxO2mmD9I1uPsvWvbB2znWy9kx07zsZDQ9G68q9htBuBixEwYE1TBdPZGv64mWBC4Rn7BgnUjY8</recordid><startdate>20060101</startdate><enddate>20060101</enddate><creator>HARDEN, T. Kendall</creator><creator>SONDEK, John</creator><general>Annual Reviews</general><general>Annual Reviews, Inc</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20060101</creationdate><title>Regulation of phospholipase C isozymes by ras superfamily GTPases</title><author>HARDEN, T. Kendall ; SONDEK, John</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c454t-fe63d3243b50318edd0689da38c6dd981a08d125995ecb5c8a7eb3c51821fa623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Analytical, structural and metabolic biochemistry</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Enzymes and enzyme inhibitors</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gene Expression Regulation, Enzymologic - physiology</topic><topic>Humans</topic><topic>Isoenzymes - genetics</topic><topic>Isoenzymes - physiology</topic><topic>ras GTPase-Activating Proteins - genetics</topic><topic>ras GTPase-Activating Proteins - physiology</topic><topic>Transferases</topic><topic>Type C Phospholipases - biosynthesis</topic><topic>Type C Phospholipases - genetics</topic><topic>Type C Phospholipases - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HARDEN, T. Kendall</creatorcontrib><creatorcontrib>SONDEK, John</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Annual review of pharmacology and toxicology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HARDEN, T. Kendall</au><au>SONDEK, John</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Regulation of phospholipase C isozymes by ras superfamily GTPases</atitle><jtitle>Annual review of pharmacology and toxicology</jtitle><addtitle>Annu Rev Pharmacol Toxicol</addtitle><date>2006-01-01</date><risdate>2006</risdate><volume>46</volume><issue>1</issue><spage>355</spage><epage>379</epage><pages>355-379</pages><issn>0362-1642</issn><eissn>1545-4304</eissn><abstract>The physiological effects of many extracellular stimuli are mediated by receptor-promoted activation of phospholipase C (PLC) and consequential activation of inositol lipid-signaling pathways. These signaling responses include the classically described conversion of PtdIns(4,5)P(2) to the Ca(2+)-mobilizing second messenger Ins(1,4,5)P(3) and the protein kinase C-activating second messenger diacylglycerol as well as alterations in membrane association or activity of many proteins that harbor phosphoinositide binding domains. Here we discuss how the family of PLCs elaborates a minimal catalytic core typified by PLC-delta to confer multiple modes of regulation on their phospholipase activities. Although PLC-dependent signaling is prominently regulated by direct interactions with heterotrimeric G proteins or tyrosine kinases, the existence of at least 13 divergent PLC isozymes promises a diverse repertoire of regulatory mechanisms for this class of important signaling proteins. We focus here on the recently realized and extensive regulation of inositol lipid signaling by Ras superfamily GTPases directly acting on PLC isozymes and conclude by considering the biological and pharmacological ramifications of this regulation.</abstract><cop>Palo Alto, CA</cop><pub>Annual Reviews</pub><pmid>16402909</pmid><doi>10.1146/annurev.pharmtox.46.120604.141223</doi><tpages>25</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0362-1642 |
ispartof | Annual review of pharmacology and toxicology, 2006-01, Vol.46 (1), p.355-379 |
issn | 0362-1642 1545-4304 |
language | eng |
recordid | cdi_proquest_miscellaneous_67618549 |
source | Annual Reviews |
subjects | Analytical, structural and metabolic biochemistry Animals Biological and medical sciences Enzymes and enzyme inhibitors Fundamental and applied biological sciences. Psychology Gene Expression Regulation, Enzymologic - physiology Humans Isoenzymes - genetics Isoenzymes - physiology ras GTPase-Activating Proteins - genetics ras GTPase-Activating Proteins - physiology Transferases Type C Phospholipases - biosynthesis Type C Phospholipases - genetics Type C Phospholipases - physiology |
title | Regulation of phospholipase C isozymes by ras superfamily GTPases |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T15%3A05%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Regulation%20of%20phospholipase%20C%20isozymes%20by%20ras%20superfamily%20GTPases&rft.jtitle=Annual%20review%20of%20pharmacology%20and%20toxicology&rft.au=HARDEN,%20T.%20Kendall&rft.date=2006-01-01&rft.volume=46&rft.issue=1&rft.spage=355&rft.epage=379&rft.pages=355-379&rft.issn=0362-1642&rft.eissn=1545-4304&rft_id=info:doi/10.1146/annurev.pharmtox.46.120604.141223&rft_dat=%3Cproquest_cross%3E1009295491%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c454t-fe63d3243b50318edd0689da38c6dd981a08d125995ecb5c8a7eb3c51821fa623%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=205854422&rft_id=info:pmid/16402909&rfr_iscdi=true |